SQZ Biotechnologies Co
DelistedCIK 1604477fmd_06QTBQ3PWAKHJN1271XFGJ1T1QManufacturing · Biological Products, (No Diagnostic Substances)Template: Standard
Coverage: Jan 01, 2019 to Sep 30, 2023, 17 periods
Latest annual · FY2022
Millions- Total revenues
- 21
- Operating income
- (81)
- Net income
- (79)
- Free cash flow
- (84)
Latest quarter · Q3 FY2023
Millions- Total revenues
- 0
- Operating income
- (24)
- Net income
- (24)
- Free cash flow
- (15)
Key stats
Open AnalysisCompound annual growth
- Revenue, 3 yearsFY2019 to FY2022
- +2.2%
SQZ Biotechnologies Co financials: quick answers
Annual figures as filed with the SEC. Each number links to the filing it came from and to its proof.
| Metric | FY2022 | FY2021 | Change | Source |
|---|---|---|---|---|
| Revenue | $21.5 million | $27.1 million | -20.7% | 10-K 2023-03-22 · proof |
| Operating income | -$80.7 million | -$68.8 million | 10-K 2023-03-22 · proof | |
| Net income | -$79.5 million | -$68.7 million | 10-K 2023-03-22 · proof | |
| Cash from operating activities | -$83.5 million | -$82.1 million | 10-K 2023-03-22 · proof | |
| Free cash flow | -$84.1 million | -$82.8 million | 10-K 2023-03-22 · proof | |
| Total assets | $99.9 million | $226.2 million | -55.8% | 10-K 2023-03-22 · proof |
| Total liabilities | $42.8 million | $102.2 million | -58.2% | 10-K 2023-03-22 · proof |
| Cash and cash equivalents | $63.7 million | $143.5 million | -55.6% | 10-K 2023-03-22 · proof |
- What was SQZ Biotechnologies Co's revenue in fiscal 2022?
- SQZ Biotechnologies Co reported revenue of $21.5 million for fiscal 2022 (the year ended Dec 31, 2022), against $27.1 million the year before (-20.7%). Source: the 10-K filed with the SEC on Mar 22, 2023. SEC
- What was SQZ Biotechnologies Co's operating income in fiscal 2022?
- SQZ Biotechnologies Co reported operating income of -$80.7 million for fiscal 2022 (the year ended Dec 31, 2022), against -$68.8 million the year before. Source: the 10-K filed with the SEC on Mar 22, 2023. SEC
- What was SQZ Biotechnologies Co's net income in fiscal 2022?
- SQZ Biotechnologies Co reported net income of -$79.5 million for fiscal 2022 (the year ended Dec 31, 2022), against -$68.7 million the year before. Source: the 10-K filed with the SEC on Mar 22, 2023. SEC
- What was SQZ Biotechnologies Co's cash from operating activities in fiscal 2022?
- SQZ Biotechnologies Co reported cash from operating activities of -$83.5 million for fiscal 2022 (the year ended Dec 31, 2022), against -$82.1 million the year before. Source: the 10-K filed with the SEC on Mar 22, 2023. SEC
- What was SQZ Biotechnologies Co's free cash flow in fiscal 2022?
- SQZ Biotechnologies Co reported free cash flow of -$84.1 million for fiscal 2022 (the year ended Dec 31, 2022), against -$82.8 million the year before. Source: the 10-K filed with the SEC on Mar 22, 2023. SEC
- What are SQZ Biotechnologies Co's total assets?
- As of Dec 31, 2022, SQZ Biotechnologies Co reported total assets of $99.9 million, against $226.2 million a year earlier (-55.8%). Source: the 10-K filed with the SEC on Mar 22, 2023. SEC
- What are SQZ Biotechnologies Co's total liabilities?
- As of Dec 31, 2022, SQZ Biotechnologies Co reported total liabilities of $42.8 million, against $102.2 million a year earlier (-58.2%). Source: the 10-K filed with the SEC on Mar 22, 2023. SEC
- What are SQZ Biotechnologies Co's cash and cash equivalents?
- As of Dec 31, 2022, SQZ Biotechnologies Co reported cash and cash equivalents of $63.7 million, against $143.5 million a year earlier (-55.6%). Source: the 10-K filed with the SEC on Mar 22, 2023. SEC
Read from the FinancialMD API on Nov 14, 2026. Values change only when a new filing is made; see the Financials tab for every period and as-of replay.
The same numbers for an agent, with proof on every value:
curl "https://api.financial.md/v1/company/financials/income_statement/standardized?company=cik:1604477&period_type=annual&limit=5"Information only, not investment advice.